P53 overexpression is a prognostic indicator in poorly differentiated, node negative and T1/T2 invasive ductal breast cancer patients

Breast

Volumn 6, Issue 4, 1997, Pages 194-201

  Andre S ^a   Pereira, H ^a   Nogueira, M ^a   Cardoso, P ^a   Bernardo, M ^a   Meneses E Sousa, J ^a   Soares, J ^a  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

POLYCLONAL ANTIBODY; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; BREAST DUCT; CANCER GRADING; CANCER SURVIVAL; CELL NUCLEUS; FEMALE; GENE OVEREXPRESSION; HUMAN; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TISSUE SECTION;

EID: 0030782179     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(97)90573-7     Document Type: Article

References (42)

1. Charpin C, DeVictor B, Andrac L, Amabile J, Bergeret D, LaVaut M, et al. p53 quantitative immunocytochemical analysis in breast carcinomas. Hum Pathol 1995; 26: 159-166.
2. Batsakis J G, El-Naggar A K. p53: 15 years after discovery. Adv Anat Pathol 1995; 2: 71-88.
3. Beck T, Weller E E, Weikel W, Brumm C, Wilkens C, Knapstein P G. Usefulness of immunohistochemical staining for p53 in the prognosis of breast carcinomas: correlations with established prognosis parameters and with the proliferation marker, MIB-1. Gynecol Oncol 1995; 57: 95-104.
4. Dunn J M, Hastrich D S, Newcomb P. Correlation between p53 mutations and antibody staining in breast carcinoma. Br J Surg 1993; 80: 1410-1412.
5. Lohmann D, Ruhri C, Schmitt M, Graeff H, Hofler H. Accumulation of p53 protein as an indicator for p53 gene mutation in breast cancer. Occurrence of false-positives and false-negatives. Diagn Mol Pathol 1993; 2: 36-41.
6. Soussi T, Legros Y, Lubin R, Ory K, Schlichtholz B. Multifactorial analysis of p53 alteration in human cancer: a review. Inst J Cancer 1994; 57: 1-9.
7. Barghava V, Thor A, Deng G, Ljung B, Moore II D H, Waldman F, et al. The association of p53 immunopositivity with tumor proliferation and other prognostic indicators in breast cancer. Mod Pathol 1994; 7: 361-368.
8. O'Malley F P, Vnencak-Jones C L, Dupont W D, Pari F, Manning S, Page D L. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Lab Invest 1994; 71: 67-70.
9. Domagala W, Harezga B, Szadowska A, Markiewski M, Weber K, Osborn M. Nuclear p53 protein accumulates preferentially in medullary and high grade ductal but rarely in lobular carcinomas. Am J Pathol 1993; 142: 669-674.
10. Martinazzi M. Expression of p53 oncoprotein in different histological types of breast carcinoma. Am J Pathol 1994; 144: 205-208.
11. Rosen P P, Lesser M L, Arroyo C D, Cranor M, Borgen P, Norton L. p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis. J Clin Oncol 1995; 13: 821-830.
12. Hurlimann J. Prognostic value of p53 protein expression in breast carcinomas. Pathol Res Pract 1993; 189: 996-1003.
13. Davidoff A M, Herndon II J E, Glover N S, Kerns B M, Pence J C, Iglehart D, et al. Relation between p53 overexpression and established prognostic factors in breast cancer. Surgery 1991; 110: 259-264.
14. Friedrichs K, Gluba S, Eidtmann H, Jonat W. Overexpression of p53 and prognosis in breast cancer. Cancer 1993; 72: 3641-3647.
15. Ostrowski J L, Sawan A, Henry L, Hennessy C, Lennard T J W, Angus B, et al. p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study. J Pathol 1991; 164: 75-81.
16. Barnes D M, Dublin E A, Fisher C J, Levison D A, Millis R R. Immunohistochemical detection of p53 in mammary carcinoma: an important new independent indicator of prognosis? Hum Pathol 1993; 24: 469-476.
17. Isola J, Visakorpi T, Holli K, Kallioniemi O. Association of overexpression of tumor supressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J Nat Cancer Inst 1992; 84: 1109-1113.
18. Visscher D W, Sarkar F H, Kothari K, Macoska J, Crissman J. Clinicopathologic significance of p53 immunostaining in adenocarcinoma of the breast. Arch Pathol Lab Med 1993; 117: 973-976.
19. Thor A D, Moore II D H, Edgerton S M, Kawasaki E S, Reihsaus E, Lynch H T, et al. Accumulation of p53 tumor supressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 1992; 84: 845-855.
20. Pietilainen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma V, Syrjanen K. Expression of p53 protein has no independent prognostic value in breast cancer. J Pathol 1995; 177: 225-232.
21. . Cunningham J M, Ingle J N, Jung S H, Cha S S, Wold L E, Farr G, et al. p53 gene expression in node-positive breast cancer: relationship to DNA ploidy and prognosis. J Nat Cancer Inst 1994; 86: 1871-1873.
22. Allred D C, Clark G M, Elledge R, Fuqua S A W, Brown R W, Chamness, et al. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 1993; 85: 200-206.
23. Bosari S, Lee A K, Viale G, Heatley G J, Coggi G. Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long term follow-up. Virchows Arch 1992; 421: 29-35.
24. Haerslev T, Jacobsen G K. An immunohistochemical study of p53 with correlations to histopathological parameters, c-erbB-2, proliferating cell nuclear antigen, and prognosis. Hum Pathol 1995; 26: 295-301.
25. Stenmark A M, Stal O, Olsen K, Nordenskjold B. p53 as a prognostic factor in stage I breast cancer. South-East Sweden breast cancer group. Br J Cancer 1995; 72: 715-719.
26. Lipponen P, Ji H, Aaltomaa S, Syrjanen S, Syrjanen K. p53 protein expression in breast cancer as related to histopathological characteristics and prognosis. Int J Cancer 1993; 55: 51-56.
27. Bosari S, Viale G. The clinical significance of p53 aberrations in human tumours. Virchows Arch 1995; 427: 229-241.
28. Hanzal E, Gitsch G, Kohlberger P, Dadak C, Miechowiecka N, Breitenecker G. Immunohistochemical detection of mutant p53-supressor gene product in patients with breast cancer: influence on metastasis-free survival. Anticancer Res 1992; 12: 2325-2329.
29. Elston C W, Ellis I O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathol 1991; 19: 403-410.
30. Page DL. Prognosis and breast cancer. Recognition of lethal and favorable prognostic types. Am J Surg Pathol 1991; 15: 334-338.
31. Joensuu H, Toikkanen S. Identification of subgroups with favorable prognosis in breast cancer. Acta Oncol 1992; 31: 293-301.
32. . Fisher B, Bauer M, Wickerham D L, Redmond C K, Fisher E R. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer 1983; 52: 1551-1556.
33. Callahan R. p53 mutations, another breast cancer prognostic factor. J Natl Cancer Inst 1992; 84: 826-827.
34. Gasparini G, Pozza F, Harris A L. Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients. J Nat Cancer Inst 1993; 85: 1206-1219.
35. Yandell D W, Thor A D. p53 analysis in diagnostic pathology. Biologic implications and possible clinical applications. Diagn Mol Pathol 1993; 2: 1-3.
36. Walker R, Dearing S, Lane D, Varley J M. Expression of p53 protein in infiltrating and in-situ breast carcinomas. J Pathol 1991; 165: 203-211.
37. Lambkin H A, Mothersill C M, Kelehan P. Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection. J Pathol 1994; 172: 13-18.
38. Pavelic Z P, Portugal L C, Gootee M S, Stambrook P J, Smith C, Mugge R E, et al. Retrieval of p53 protein in paraffin-embedded head and neck tumor tissues. Arch Otolaryngol Head Neck Surg 1993; 119: 1206-1209.
39. Campani D, Cecchetti D, Bevilacqua G. Immunocytochemical p53 detection by microwave oven heating of routinely formalin-fixed paraffin sections. J Pathol 1993; 171: 151-152.
40. Umekita Y, Takasaki T, Yoshida H. Expression of p53 protein in benign epithelial hyperplasia, atypical ductal hyperplasia, non-invasive and invasive mammary carcinoma: an immunohistochemical study. Virchows Archiv 1994; 424: 491-494.
41. Dowell S P, Hall P A. The p53 tumor suppressor gene and tumor prognosis: Is there a relationship? J Pathol 1995; 177: 22-24.
42. Poller D N, Roberts E C, Bell J A, Elston C W, Blamey R W, Ellis I O. p53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein. Hum Pathol 1993; 24: 463-468.